:

Homeland Security

NIAID Issues BAA for Bio-Defense Vaccine Enhancement

DDN

Wednesday, October 3rd, 2007

SHARE:

The National Institute of Allergy and Infectious Diseases (NIAID), with funding provided in whole or in part by the Biomedical Advanced Research and Development Agency, plans to fund organizations with demonstrated vaccine product development experience to produce a vaccine candidate either for a NIAID Category A or B Priority Pathogen or a candidate third generation anthrax vaccine. Sol. No. BAA-NIH-BARDA-NIAID-DMID-AI2007007. Respond by Jan. 22, 2008. Contact: Jordan Pulaski, contract specialist, 301-451-480-4675, jpulaski@niaid.nih.gov.

HII Executive Outlines Its Shipbuilding Acceleration Strategy

An HII [HII] shipbuilding executive last week told lawmakers how the company plans to improve and accelerate shipbuilding throughout via workforce improvements, adding new shipbuilding infrastructure and reinforcing distributed shipbuilding […]

Congress

House Sends Dec. 11 CR With Ship Construction Funds To Trump’s Desk For Final Signature

The House on Tuesday passed a stopgap funding bill to keep the government open through Dec. 11, sending the temporary funding measure that also includes funds to support ongoing shipbuilding […]

Missile Defense

Guetlein On Golden Dome: ‘We Cannot Protect This Nation And Bankrupt It At The Same Time’

While there has been criticism among missile defense advocates of Golden Dome’s development pace after the signing of an executive order in January last year, Space Force Gen. Michael Guetlein, […]

Missile Defense

Interview with Rep. Jeff Crank (R-Colo.), co-chair of the Golden Dome Caucus

Rep. Jeff Crank (R-Colo.), a co-chair of the Golden Dome Caucus in Congress and a member of the House Armed Services Committee’s strategic forces panel, discusses the transformative defense investments […]